Search

Search Constraints

You searched for: Author/Creator Hykin, Philip

Search Results

1. Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study. (10th June 2010)

2. Clinical efficacy and mechanistic evaluation of aflibercept for proliferative diabetic retinopathy (acronym CLARITY): a multicentre phase IIb randomised active-controlled clinical trial. Issue 9 (14th September 2015)

3. Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial. Issue 5 (May 2018)

4. Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial. Issue 10085 (3rd June 2017)

5. Diagnostic accuracy of disorganization of the retinal inner layers in detecting macular capillary non‐perfusion in diabetic retinopathy. (24th June 2015)

6. Differences in the topographic profiles of retinal thickening in eyes with and without serous macular detachment associated with diabetic macular oedema. Issue 2 (13th November 2013)

7. EFFICACY AND SAFETY OF INTRAVITREAL AFLIBERCEPT USING A TREAT-AND-EXTEND REGIMEN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The ARIES Study. Issue 9 (September 2021)

9. Key drivers of visual acuity gains in neovascular age-related macular degeneration in real life: findings from the AURA study. Issue 12 (30th March 2016)

10. Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration. Issue 2 (5th September 2014)